R. DALE HUGHES PROFESSORSHIP IN ONCOLOGY
Established in 2002 through commitments made by R. Dale and Frances M. Hughes and other donors in 1999

R. DALE HUGHES began making regular trips from his home in East Stroudsburg, Pennsylvania, for treatment at the Oncology Center in 1987. In gratitude for the care he received, he and his wife, FRANCES M. HUGHES, made the lead commitment to create this professorship to advance urological cancer research and treatment. Mrs. Hughes was a public school teacher in Pennsylvania and Connecticut before retiring. Mr. Hughes headed several printing companies in the northeast during an impressive career spanning more than four decades. Monroe Printing, which he acquired in 1969, was the last of these and, under his leadership, had increased sales seven-fold by the time he retired in 1990.

Even though he spent part of the year in Florida, he continued as a director of the Pocono Community Bank in East Stroudsburg, which he helped to establish. Active in community affairs in Monroe County, Pennsylvania, Mr. and Mrs. Hughes generously supported scholarships at local colleges, area health care facilities, and the county library, which is named for the Hughes family. Mr. Hughes died in 2002.

 

"My life has only been in serious danger twice: once as a young man in World War II and now, living with progressing prostate cancer. I hope Hopkins physicians will, in time, find a way to retard or eliminate these cancer cells...if not for me, then for others who will surely follow."
R. Dale Hughes

 

MARIO A. EISENBERGER, the inaugural R. Dale Hughes Professor in Oncology, came to Hopkins in 1993 and holds joint appointments in the departments of Urology and Oncology. One of the leading authorities in the world on prostate cancer, Dr. Eisenberger developed the James Stine Prostate Cancer Clinical Research Office, a data-management office and serum repository for patients receiving treatment in clinical trials at Johns Hopkins. Dr. Eisenberger is leading efforts to develop new drug and chemotherapy combinations to address prostate and urological cancers. He was born and educated in Brazil, and continued his training in the United States, serving with the National Cancer Institute and at the University of Maryland Cancer Center where he worked on the forefront of therapeutic research for urologic cancer.